Drugs that contain Tobramycin

1. Drug name - TOBI PODHALER

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7368102 MYLAN SPECIALITY LP Pulmonary delivery of aminoglycosides Dec, 2022

(2 months from now)

US9421166 MYLAN SPECIALITY LP Pulmonary delivery of aminoglycoside Dec, 2022

(2 months from now)

US8715623 MYLAN SPECIALITY LP Pulmonary delivery of aminoglycoside Dec, 2022

(2 months from now)

US7516741 MYLAN SPECIALITY LP Aerosolization apparatus with feedback mechanism Jan, 2024

(1 year, 3 months from now)

USRE47526 MYLAN SPECIALITY LP Aerosolization apparatus with air inlet shield Apr, 2024

(1 year, 6 months from now)

US8069851 MYLAN SPECIALITY LP Aeorosolization apparatus with air inlet shield Sep, 2024

(1 year, 11 months from now)

US8664187 MYLAN SPECIALITY LP Methods of treatment of endobronchial infections Jun, 2025

(2 years from now)

US7559325 MYLAN SPECIALITY LP Aerosolization apparatus with air inlet shield Oct, 2025

(3 years from now)

US8869794 MYLAN SPECIALITY LP Aerosolization apparatus with capsule puncturing member Sep, 2028

(5 years from now)

US10207066 MYLAN SPECIALITY LP Aerosolization apparatus with capsule puncture alignment guide Nov, 2030

(8 years from now)

Treatment: Treatment of cystic fibrosis patients with pseudomonas aeruginosa

Dosage: POWDER;INHALATION

More Information on Dosage
Strength Dosage Availability
28MG POWDER;INHALATION Prescription

availability in other generic markets.

Click on the highlighted region to filter.